Measured Risk Portfolios’s LifeMD LFMD Stock Holding History

Measured Risk Portfolios’s Portfolio LFMD Stock Details LFMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-3,000	Closed	-$14.8K	–	196
2024 Q4	$14.8K	Buy	+3,000	New	+$15.7K	0.02%	155

Other funds holding LFMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Measured Risk Portfolios's LFMD Position: Q1 2025 in Review

Measured Risk Portfolios sold out of LifeMD (LFMD) in Q1 2025, closing a stake of 3,000 shares — an estimated $14.8K sold.

Measured Risk Portfolios first reported a position in LFMD in Q4 2024 and held it in 1 quarter. The position peaked at $14.8K in Q4 2024. 103 funds tracked by Wall St. Rank hold LFMD as of Q1 2025.

Measured Risk Portfolios reported no remaining LifeMD position as of Q1 2025 after selling out during the quarter.
Measured Risk Portfolios sold 3,000 LifeMD shares in Q1 2025, an estimated $14.8K.
Measured Risk Portfolios first reported a position in LifeMD in Q4 2024 and held it in 1 quarter.
Measured Risk Portfolios's LifeMD position peaked at $14.8K in Q4 2024.
103 funds tracked by Wall St. Rank held LifeMD as of Q1 2025.

Based on Measured Risk Portfolios's 13F filing for Q1 2025, filed 13 May 2025.